Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy
- PMID: 21149430
- DOI: 10.1542/peds.2010-0929
Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy
Abstract
Objective: Serum alanine transaminase (ALT) and aspartate transaminase (AST) levels are commonly used as biochemical indicators of hepatocellular injury but can also detect occult muscle disease. High concomitant serum creatine phosphokinase (CPK) levels can point to muscle as the source of high transaminase levels. Nevertheless, clinicians may be reluctant to attribute high transaminase levels to muscle.
Methods: Study patients were boys with a genetic or biopsy-confirmed dystrophinopathy whose concomitant serum CPK, ALT, and AST levels were measured.
Results: We report 82 enzyme data sets from 46 patients with Duchenne muscular dystrophy (DMD) and 9 with Becker muscular dystrophy. Our results show a linear relationship between serum CPK and serum ALT and AST and a logarithmic relationship between serum enzyme levels and age for boys with DMD. We developed a mathematical model to predict serum ALT and AST levels when the serum CPK level and age are known. For 6 boys, initial failure to consider muscle as a cause of high transaminase levels led to delay of diagnosis and extensive testing for hepatic dysfunction. A second group of 4 boys with known DMD were investigated for liver disease after high transaminase levels were detected. Serum transaminase levels were highest in ambulant boys with DMD, whose levels reached 1220 U/L (ALT) (22.6 times higher than upper-limit normal levels) and 801 U/L (AST) (12.3 times higher than upper-limit normal levels).
Conclusions: By recognizing muscle as a potential source of serum transaminase levels, clinicians can avoid unnecessary and invasive procedures, expedite clinical diagnosis, and avoid unnecessary cessation of concomitant drug therapy.
Similar articles
-
Cognitive and psychological profile of males with Becker muscular dystrophy.J Child Neurol. 2008 Feb;23(2):155-62. doi: 10.1177/0883073807307975. Epub 2007 Dec 3. J Child Neurol. 2008. PMID: 18056690
-
Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.Am J Phys Med Rehabil. 2020 Dec;99(12):1121-1128. doi: 10.1097/PHM.0000000000001500. Am J Phys Med Rehabil. 2020. PMID: 32520799
-
Incidental raised transaminases: a clue to muscle disease.Ann Trop Paediatr. 2006 Dec;26(4):345-8. doi: 10.1179/146532806X152872. Ann Trop Paediatr. 2006. PMID: 17132300
-
The enzymology of skeletal muscle disorders.Crit Rev Clin Lab Sci. 1984;20(2):153-90. doi: 10.3109/10408368409165773. Crit Rev Clin Lab Sci. 1984. PMID: 6373145 Review.
-
Elevated aminotransferase activity as an indication of muscular dystrophy: case reports and review of the literature.Can J Gastroenterol. 1996 Oct;10(6):389-93. doi: 10.1155/1996/213209. Can J Gastroenterol. 1996. PMID: 9193775 Review.
Cited by
-
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial.J Neuromuscul Dis. 2021;8(5):769-784. doi: 10.3233/JND-210689. J Neuromuscul Dis. 2021. PMID: 34120912 Free PMC article. Clinical Trial.
-
Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.J Neuromuscul Dis. 2015 Sep 2;2(3):241-255. doi: 10.3233/JND-140066. J Neuromuscul Dis. 2015. PMID: 26870665 Free PMC article.
-
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model.Nat Commun. 2024 Sep 26;15(1):7530. doi: 10.1038/s41467-024-48204-5. Nat Commun. 2024. PMID: 39327422 Free PMC article.
-
Biomarkers of Duchenne muscular dystrophy: current findings.Degener Neurol Neuromuscul Dis. 2018 Jan 25;8:1-13. doi: 10.2147/DNND.S121099. eCollection 2018. Degener Neurol Neuromuscul Dis. 2018. PMID: 30050384 Free PMC article. Review.
-
Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.PLoS One. 2020 Oct 9;15(10):e0240562. doi: 10.1371/journal.pone.0240562. eCollection 2020. PLoS One. 2020. PMID: 33035276 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical